NFIB Human shRNA Plasmid Kit (Locus ID 4781)

CAT#: TG311191

NFIB - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided


Product Images

Specifications

Product Data
Locus ID 4781
Synonyms CTF; HMGIC/NFIB; MACID; NF-I/B; NF1-B; NFI-B; NFI-RED; NFIB2; NFIB3
Vector pGFP-V-RS
E. coli Selection Kanamycin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Kit Components NFIB - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 4781). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq BC024316, NM_001190737, NM_001190738, NM_001282787, NM_005596, NM_005596.1, NM_005596.2, NM_005596.3, NM_001190738.1, NM_001190737.1, NM_001282787.1, BC001283, NM_001369458, NM_001369459, NM_001369460, NM_001369463, NM_001369464, NM_001369465, NM_001369466, NM_001369467, NM_001369472, NM_001369473, NM_001369474, NM_001369475, NM_001369476, NM_001369480, NM_001369481, NR_161385, NM_001369461, NM_001369462, NM_001369468, NM_001369469, NM_001369470, NM_001369471, NM_001369477, NM_001369478, NM_001369479, NR_161382, NR_161383, NR_161384, NM_001190737.2
UniProt ID O00712
Summary Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.[UniProtKB/Swiss-Prot Function]
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact tech@clinisciences.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.

For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at tech@clinisciences.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

Documents